◎ Case Input → Guided Discovery Plan Output

Diabetic Foot Osteomyelitis + Suspected PE

53-year-old female · Poly-crisis · Guided Discovery Plan · Modules 0–42 + Frameworks A–D

Poly-crisisComplexity
Acute-on-ChronicTimeline
★★★6 CoreModules
7 Red FlagsCognitive
9 Key GapsData
3 PipelinesSessions
Case Input — SOAP Note
SSubjective
Patient is a 53-year-old female with a known 12-year history of diabetes. She presented with a non-healing ulcer on her right foot which has been present for approximately one month. The primary acute complaint is new-onset shortness of breath (dyspnea), requiring supplemental oxygen.
OObjective
  • Vitals: SpO₂ 95% on 3 L/hr O₂ via nasal cannula · HR 100 bpm · BP 115/66 mmHg
  • Right great toe: Non-healing ulcer with surrounding abscess; osteomyelitis confirmed on imaging
  • Left foot: Bandaged (undescribed)
  • Chest X-Ray: Clear — no infiltrates, no effusion, no pulmonary oedema
  • Venous Doppler (right LL): No DVT; confirmed abscess with likely osteomyelitis of distal phalanx
  • Random BGL: Extreme variability — 108 to 514 mg/dL
  • D-dimer: Elevated — in the thousands
AAssessment
  • Acute Hypoxic Respiratory Failure: Working Dx — Pulmonary Embolism (PE). Basis: acute hypoxia + clear CXR + elevated D-dimer. DVT not identified on right lower limb Doppler.
  • Uncontrolled DM2: Infected Diabetic Foot Ulcer with confirmed osteomyelitis (likely source of hypercoagulable state). Severe glycaemic variability — failing insulin regimen.
PPlan
  • PE: Start LMWH (Enoxaparin 1 mg/kg q12h) after checking renal function. Arrange STAT CTPA. Supplemental O₂ to maintain SpO₂ >94%.
  • Infection/Sepsis: Urgent surgical/orthopaedic consult for debridement. Broad-spectrum IV antibiotics with bone penetration.
  • Diabetes: Convert to basal-bolus insulin from sliding scale. Consider endocrinology consult.
This SOAP note was submitted to the VibeRounds Guided Discovery Agent for educational reasoning analysis only. All AI-generated outputs require independent clinical verification before any patient-care action. This is not a clinical decision-support tool. — Dr. Avinash Kumar Gupta · VibeRounds
Section A — Case Fingerprint
Complexity
Poly-crisis
PE + osteomyelitis/sepsis + uncontrolled DM2 — three simultaneously life-threatening threads
Timeline
Acute-on-Chronic
1-month ulcer, 12-year DM; acute hypoxic respiratory failure superimposed
Learner
Not Stated
Module 0 will clarify role and learning goal
Data State
Evolving / Incomplete
CTPA pending; renal function not reported; cultures pending; left foot undescribed
Setting
High-resource Inpatient
CTPA, LMWH, IV antibiotics, and surgical consult all presupposed as available
Anchor Dx
Pulmonary Embolism
Stated as primary diagnosis before CTPA confirmed — anchoring bias risk DETECTED
⚠ Red Flags — Cognitive & Clinical
  • CTPA not yet performed — PE is presumed, not confirmed; anticoagulation already initiated
  • D-dimer "in the thousands" in a patient with active infection and osteomyelitis — near-zero specificity in this inflammatory context; evidential weight overstated
  • HR 100 + BP 115/66 — does not distinguish submassive PE from early septic shock
  • Left foot is bandaged and completely uncharacterised — bilateral lower-limb disease unexplored
  • Right lower limb DVT negative — source of PE (if confirmed) unlocated; pelvic/upper-extremity/in-situ thrombosis not considered
  • Glycaemic range 108–514 mg/dL — cause vs. consequence of acute deterioration not formally attributed
  • No renal function, no blood cultures, no CRP/procalcitonin/WBC documented — significant data void
◎ Key Gaps — Missing Data
  • CTPA (confirmatory imaging for PE)
  • eGFR/creatinine — required before LMWH dosing
  • Blood cultures × 2 prior to antibiotics
  • HbA1c (long-term glycaemic control)
  • Inflammatory markers (CRP, WBC, procalcitonin, ESR)
  • Left foot — clinical description, imaging, severity staging
  • Echocardiogram — RV strain assessment; baseline cardiac function
  • Antibiotic identity, dosing, and duration plan
  • DVT search extended to pelvis and upper limbs
Section B — Recommended Modules (Ranked)
★★★ Core Modules
★★★
Module 0
Cold-Start Orientation
Always first — learner role and session goal not stated; must orient before any reasoning begins
★★★
Module 1
Socratic Clinical Reasoning
Active diagnostic question: PE presumed but unconfirmed; sepsis vs. PE vs. combined physiology not yet separated
★★★
Module 12
Differential Diagnosis Deepdive
Leading diagnosis anchored before confirmatory imaging; differential for acute hypoxia in this host has not been formally ranked
★★★
Module 28
Diagnostic Time-Out
Anchoring Bias Detected D-dimer in an inflamed host used as near-confirmatory PE evidence before CTPA
★★★
Module 33
"Why Now?" Precipitant Hunter
12-year DM + 1-month ulcer → acute decompensation today; the infection→PE causal chain is asserted, not interrogated
★★★
Module 38
Poly-Crisis & Cascading Failure Simulator
Three simultaneous life-threatening problems with bidirectional interactions; single-problem reasoning frameworks are insufficient
★★ Supportive Modules
★★
Module 18
Causal vs. Probabilistic Reasoning
D-dimer specificity in active infection must be quantified, not assumed; base-rate reasoning absent from plan
★★
Module 26
Bias Auditing
At least three active biases: anchoring (PE), premature closure (before CTPA), search satisfaction (stopped at PE)
★★
Module 31
First-Principles Pathophysiology Mapping
Virchow's Triad → PE link is asserted; unpacking mechanistically exposes alternative explanations
★★
Module 13
Medication Reconciliation & Polypharmacy
Insulin unnamed; antibiotics unspecified; enoxaparin dose requires renal function not yet reported
★★
Module 42
Clinical Pre-Mortem
High-stakes: anticoagulation in active septic focus, surgical timing, glycaemic instability — compounding failure paths
★ Enrichment Modules
Module 5
Real-Time Case Review & Data Audit
Multiple data gaps; structured audit pass surfaces which decisions rest on incomplete information
Module 35
Epistemic Certainty Mapping & Calibration
Plan proceeds with high confidence on presumptive diagnosis; explicit certainty stratification would prevent premature commitment
Module 36
Bayesian Probability / Likelihood Ratio Engine
Wells PE score, pre-test probability, and D-dimer LR not formally calculated or stated anywhere in the plan
Module 14
Resource-Constrained Clinical Reasoning
If setting is lower-resource or patient requires transfer, the plan needs a viable alternative to CTPA + LMWH
Module 16
Basic Science ↔ Clinical Integration
DM-related hypercoagulability, endothelial dysfunction, and impaired immunity are foundational to understanding why this patient is here
Frameworks to Activate
Framework A — Humanistic Persona Framework C — Bloom's Revised Taxonomy Framework D — Critical Awareness Framework
Framework D is the primary active framework — anchoring bias in the Anchor Dx is the dominant cognitive hazard in this case.
Section C — Guided Discovery Pipelines
Pipeline 1 — Session 1
Orientation & Primary Diagnostic Reasoning · Recommended starting point
Initiation
Module 0 Confirm learner role (student / resident / self-directed); confirm de-identification; establish session goal — is this about PE diagnosis, diabetic foot management, or the poly-crisis interaction?
Execution
Module 1 Socratic reasoning — BEFORE looking at the Assessment, construct an independent differential for acute hypoxia + clear CXR + elevated D-dimer in a 53-year-old with active osteomyelitis and uncontrolled DM. Rank and weight each item.
Module 12 Differential Deepdive — take the top three diagnoses and assign pre-test probabilities; identify the single discriminating test for each.
Module 28 Diagnostic Time-Out — freeze before accepting PE as confirmed; audit the strength of evidence for and against in this specific inflammatory host.
Closure / Review
Module 1 Compare learner's pre-CTPA differential against the plan's working diagnosis; identify the single highest-yield missing data point; set difficulty ratchet for Session 2.
Pipeline 2 — Session 2
Poly-Crisis Reasoning & Bias Correction · Data scrutiny
Initiation
Module 33 "Why Now?" Precipitant Hunter — map the sequence from DM → foot ulcer → osteomyelitis → hypercoagulability → acute decompensation. Where is the causal chain weakest?
Execution
Module 38 Poly-Crisis Simulator — model bidirectional interactions: how does anticoagulation affect the septic focus? How does surgical debridement timing interact with PE management? How does glycaemic instability alter both?
Module 18 Causal vs. Probabilistic Reasoning — what is the actual positive predictive value of a D-dimer "in the thousands" in a patient with osteomyelitis and uncontrolled DM?
Module 26 Bias Audit — name and neutralise the active biases: anchoring, premature closure, search satisfaction.
Closure / Review
Synthesis Produce a revised, probability-weighted differential holding PE, sepsis-driven hypoxia, and mixed aetiology as simultaneous live hypotheses until CTPA result is known.
Pipeline 3 — Session 3
Evidence, Safety & Management Synthesis · Optional/Advanced
Initiation
Module 13 Medication Reconciliation — audit enoxaparin dosing against renal function; identify the current insulin regimen; flag antibiotic selection against likely organisms in diabetic osteomyelitis.
Execution
Module 42 Clinical Pre-Mortem — walk forward three plausible failure scenarios from today's plan and design a safety checklist for each.
Module 31 First-Principles Pathophysiology Mapping — reconstruct the mechanistic link between DM2, immune dysfunction, infection, hypercoagulability, and PE; identify one point in the chain where earlier intervention would have prevented today's crisis.
Module 35 Epistemic Certainty Mapping — for each item in the management plan, assign a certainty level (confirmed / probable / speculative) so clinical decisions are transparently stratified.
Closure / Review
Module 9 Synthesise a one-page case summary suitable for handover or N-of-1 write-up if warranted; identify two evidence gaps as the basis for a literature search.
Section D — Discovery Point Plan

All questions are anchored to specific findings from this case — not generic prompts.

Module 1 — Socratic Clinical Reasoning
DP-1.1Before you read the Assessment: a 53-year-old with active osteomyelitis, glucose up to 514, HR 100, BP 115/66, and SpO₂ 95% on 3 L O₂ — what are your top five diagnoses for this acute hypoxia picture, and in what order do you rank them before knowing the D-dimer?
DP-1.2The chest X-ray is clear. Does a clear CXR make PE more likely, or does it simply eliminate some alternatives? Which diagnoses does it rule OUT versus which does it merely fail to rule IN?
DP-1.3Heart rate is 100 and BP is 115/66 — what is the hemodynamic significance of this combination? Does this picture fit uncomplicated PE, submassive PE, or early septic shock — and what clinical signs would distinguish them at the bedside right now?
DP-1.4The right lower limb DVT is negative. Does this make PE less likely, or equally likely, or does it shift your thinking about the source of any clot? Name two anatomical sources of PE other than the lower limb veins.
Module 12 — Differential Diagnosis Deepdive
DP-12.1D-dimer is "in the thousands." In a patient with active bone infection, soft-tissue abscess, uncontrolled hyperglycaemia, and likely systemic inflammation — what is your estimate of the probability that this D-dimer elevation is due to PE specifically, versus a non-specific pro-inflammatory state?
DP-12.2Construct a differential for acute hypoxia with a clear CXR in this patient. Rank: PE, sepsis-related V/Q mismatch, early ARDS from sepsis, acute cardiac event, and aspiration. Assign a probability estimate for each before the CTPA result.
DP-12.3If the CTPA comes back NEGATIVE for PE, what is your revised working diagnosis, and what investigations would you immediately add?
Module 28 — Diagnostic Time-Out Anchoring Triggered
DP-28.1The plan commits to therapeutic anticoagulation BEFORE the CTPA is reported. Name the clinical and safety consequences if the CTPA is negative and the true diagnosis is septic emboli, Gram-negative sepsis, or cardiac event. Was the decision to anticoagulate first justified?
DP-28.2The Assessment explicitly states "the negative DVT study does not rule out PE." True — but does the negative DVT study LOWER your post-test probability for PE at all? How should it recalibrate the anchor?
DP-28.3Has the Wells PE Score been formally calculated for this patient? Walk through each Wells criterion using the data in the SOAP note and compute the score. Does the result support or challenge the current anchor?
Module 33 — "Why Now?" Precipitant Hunter
DP-33.1This patient has had diabetes for 12 years and the foot ulcer for one month. The acute respiratory crisis is presenting now. What event or tipping point in the past 24–72 hours would explain today's acute decompensation? Generate three plausible precipitating timelines.
DP-33.2The glycaemic range spans 108 to 514 mg/dL. Is this variability the cause of the acute deterioration, a consequence of the physiological stress response, or both? Mechanistically, how does extreme glycaemic variability interact with coagulation, immune function, and wound healing simultaneously?
DP-33.3The left foot is bandaged and undescribed. Could pathology in the left foot be contributing to the clinical picture? What would a "Why Now?" analysis require you to know about the left foot before closing this question?
Module 38 — Poly-Crisis & Cascading Failure Simulator
DP-38.1You are anticoagulating a patient who has an active abscess with osteomyelitis. Map the second- and third-order consequences: how does therapeutic anticoagulation affect surgical management? What is the threshold for bridging or reversing anticoagulation if urgent surgery is needed?
DP-38.2Sepsis and PE are both live hypotheses requiring different therapeutic priorities. If you optimise for PE and delay surgery, what is the risk? If you prioritise surgery and hold anticoagulation, what is the risk? How do you hold both imperatives simultaneously?
DP-38.3In a patient simultaneously managing presumed PE and active osteomyelitis, what is the target glucose range for the next 48 hours, and why is BOTH hypoglycaemia AND hyperglycaemia dangerous in this specific context?
Module 18 — Causal vs. Probabilistic Reasoning
DP-18.1The causal chain asserted is: DM2 → DFU → osteomyelitis → hypercoagulability → PE. Evaluate each arrow: which links are mechanistically established, which are plausible but assumed, and which are speculative?
DP-18.2Using a probabilistic lens: what is the base rate of PE in a 53-year-old hospitalised female with active infection and immobility? Now apply the likelihood ratio of a D-dimer "in the thousands" in that specific inflammatory context. Does the posterior probability justify the presumptive diagnosis?
Module 26 — Bias Auditing
DP-26.1Identify the primary cognitive bias in this SOAP note. The D-dimer result appears in the labs, and within one section the diagnosis shifts to PE. Name this bias pattern and describe precisely how it is operating in this case.
DP-26.2The plan lists three problems but only PE receives an urgent diagnostic workup. Could premature closure on the PE label be suppressing a concurrent diagnosis — such as early septic shock or demand ischaemia — that has equal or greater immediate mortality risk?
Module 42 — Clinical Pre-Mortem
DP-42.1It is 72 hours from now. This patient has deteriorated. Imagine three distinct pathways: one where PE was correct but undertreated; one where PE was wrong and anticoagulation caused harm; one where the foot was the primary driver and source control was delayed. What early warning signs, available now, could have signalled each path?
DP-42.2Enoxaparin requires renal dosing adjustment. Renal function has not been reported. Walk through the consequence of administering 1 mg/kg BD to a patient with unrecognised renal impairment from 12 years of DM2 — what adverse event are you pre-empting, and what is your safety check before the first dose?
Module 13 — Medication Reconciliation
DP-13.1The plan converts the patient from "sliding scale" to basal-bolus insulin but does not name the current regimen or doses. What information is needed before safely initiating a new insulin regimen in a patient who is NPO-risk (potential surgical candidate) and haemodynamically borderline?
DP-13.2The antibiotics are described as "broad-spectrum IV with good bone penetration" but are not named. What are the two or three first-line regimens for diabetic foot osteomyelitis, and what interactions or renal dose adjustments do they require alongside enoxaparin and insulin?
Section E — Session Expectations (Bloom's Revised Taxonomy)

After each module session, the learner will be able to:

Module 0UNDERSTAND the contract between learner, AI, and case data, and APPLY de-identification standards before any prompt is submitted.
Module 1CONSTRUCT an independent ranked differential for acute hypoxia with clear CXR in a diabetic with active osteomyelitis without AI cueing, and EVALUATE where reasoning diverged from the Socratic debrief.
Module 12EVALUATE the pre-test probability of PE versus sepsis-driven hypoxia in this specific inflammatory host, and APPLY likelihood ratios to a D-dimer result in the context of active infection.
Module 28EVALUATE whether anchoring bias distorted diagnostic closure before confirmatory imaging, and REORDER the differential to hold PE, septic physiology, and cardiac aetiology as simultaneous live hypotheses.
Module 33ANALYSE the 12-year disease trajectory to identify the precipitating cascade that converted chronic disease into acute poly-crisis, and GENERATE three plausible "why now?" timelines grounded in the case data.
Module 38ANALYSE the bidirectional interactions between simultaneous management of presumed PE and active osteomyelitis, and CREATE a decision matrix for anticoagulation-vs-surgery timing that accounts for glycaemic instability.
Module 18COMPARE the outputs of causal (mechanism-first) and probabilistic (base-rate-first) reasoning applied to this case, and EVALUATE which links in the infection-to-PE causal chain are established versus assumed.
Module 26CREATE a named inventory of the cognitive biases active in this SOAP note (anchoring, premature closure, search satisfaction) and DESIGN one mitigation strategy per bias applicable at the bedside.
Module 42EVALUATE three plausible deterioration pathways from the current management plan and GENERATE a pre-emptive safety checklist specific to anticoagulation in active sepsis, surgical timing, and renal-adjusted dosing.
Module 13APPLY a structured polypharmacy lens to identify the highest-priority medication risk (enoxaparin dosing without confirmed renal function) and SYNTHESISE a safe reconciliation checklist before the next prescribing decision.
Module 31CONSTRUCT a first-principles pathophysiology map linking DM2 → endothelial dysfunction → hypercoagulability → thromboembolism, and IDENTIFY the mechanistic step most amenable to earlier clinical intervention.
Module 35CREATE a certainty-level table (confirmed / probable / speculative) for each diagnosis and management decision in the plan, and EVALUATE which decisions are being made on speculative foundations.
Section F — Learner Routing Note

This case is high-yield precisely because it is seductive — the D-dimer is elevated, the CXR is clear, and PE fits neatly. That seductive clarity is the learning hazard. Your first priority is Modules 1, 12, and 28: build your differential independently, then run the Diagnostic Time-Out before you accept the anchor.

Module 33 ("Why Now?") is your second essential stop because this case contains a 12-year backstory compressed into one acute presentation. Understanding the precipitant cascade is what separates reactive management from true clinical reasoning.

If your time is limited, run Module 1 → Module 28 → Module 38 in a single session. Those three will expose the highest-stakes reasoning gaps. Module 42 (Pre-Mortem) should be non-negotiable before this patient goes to the ward — the anticoagulation-in-active-sepsis tension and the missing renal function data are genuine safety concerns that the pre-mortem will surface explicitly.

Module 13 (Medication Reconciliation) is a mandatory safety stop before any prescribing decision in this case — enoxaparin dosing, the unspecified antibiotic regimen, and the unnamed insulin protocol all require reconciliation against data not yet in the chart.

Session 3 (Evidence + Pre-Mortem + Synthesis) is recommended if you want to convert this case into a structured presentation or N-of-1 write-up. The intersection of sepsis, hypercoagulability, and DM2 in a younger woman is a publishable clinical vignette.

All outputs above are learning observations generated for clinical reasoning training under the VibeRounds Socratic AI Paradigm. Every finding, suggested question, and module recommendation requires independent clinical verification by a supervising clinician before being acted upon. This is not a clinical decision-support tool. — VibeRounds Guided Discovery Agent · authored by Dr. Avinash Kumar Gupta